drugset / Trial / NCT00507546

Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia

NCT00507546

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine if replacing melatonin function with a melatonin agonist (ramelteon) in individuals that lack endogenous melatonin production (tetraplegia) helps to alleviate self-reported sleep disruption.

Timeline

Start
2007-07
Primary completion
2010-12
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg